Results Fluicell AB
-
Spheroid Bioprinting for disease modeling
-4d
-
Fluicell makes in vitro development progress in type 1 diabetes therapeutics program
-4d
-
Dynaflow Resolve used in research showing potential new ways to treat pain
-4d
-
Bioprinted liver model application note
-4d
-
Closing the loop on type 1 diabetes – Therapeutic development whitepaper
-4d
-
Microenvironment modeling with high precision bioprinting
-4d
-
Bioprinted cancer models using de-cellularized tumors
-4d
-
Fluicell initiates in vivo studies in tissue-based type 1 diabetes treatment program
-4d
-
Fluicell initiates IPSC-based type 1 diabetes therapeutic development
-4d
-
Fluicell recieves Eurostars grant
-4d